Arie Belldegrun, Chairman, President and CEO at Kite Pharma, Inc. (KITE), bought 17,000 shares at $68.57 ($1.2M) on 2017-05-09, disclosed to the SEC on 2017-05-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALLO | BUY | 2020-06-04 | $6.9M | — | Filing → |
| ALLO | BUY | 2019-02-13 | $3.5M | — | Filing → |
| KITE | SELL | 2017-09-27 | $9.5M | — | Filing → |